{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["94(4)"],"submitter":["Akingbola TS"],"funding":["Doris Duke Charitable Foundation"],"journal":["American journal of hematology"],"pagination":["E112-E115"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6440541"],"repository":["biostudies-literature"],"pubmed_title":["\"Maximum tolerated dose\" vs \"fixed low-dose\" hydroxyurea for treatment of adults with sickle cell anemia."],"pmcid":["PMC6440541"],"funding_grant_id":["2013140"],"pubmed_authors":["Sonubi O","Hsu LL","Gordeuk VR","Molokie R","Cooper RS","Tayo BO","Zhang X","Akingbola TS","Han J","Saraf SL","Ezekekwu CA"],"additional_accession":[]},"is_claimable":false,"name":"\"Maximum tolerated dose\" vs \"fixed low-dose\" hydroxyurea for treatment of adults with sickle cell anemia.","description":null,"dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Apr","modification":"2025-04-04T09:44:28.097Z","creation":"2025-04-04T09:44:28.097Z"},"accession":"S-EPMC6440541","cross_references":{"pubmed":["30663794"],"doi":["10.1002/ajh.25412"]}}